Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 3;15(15):3941.
doi: 10.3390/cancers15153941.

Survival after Pure (Acute) Erythroid Leukemia in the United States: A SEER-Based Study

Kriti Gera  1 , Daniela Martir  1 , Wei Xue  2 , John R Wingard  3
Affiliations

Survival after Pure (Acute) Erythroid Leukemia in the United States: A SEER-Based Study

Kriti Gera et al. Cancers (Basel). .

Abstract

Background: Acute erythroid leukemia (AEL), also known as pure erythroid leukemia, is a rare subtype of acute myeloid leukemia (AML) characterized by the proliferation of malignant erythroid precursors. Outcome data at the population level are scarce.

Methods: We performed a retrospective analysis of the Surveillance Epidemiology and End Results (SEER) database. All cases with a histologically confirmed diagnosis of acute (pure) erythroid leukemia during the period of 2000-2019 were included in the study. The Kaplan-Meier method was used to perform survival analysis. The significance of differences between overall survival (OS) was analyzed using the log-rank test.

Results: In total, 968 patients were included in the study. The median age was 68 years (range 0-95), 62% of patients were males, and 62.5% (n = 605) were treated with chemotherapy. The median OS for <18, 18-49, 50-64, 65-79 and 80+ age groups was 69, 18, 8, 3 and 1 month, respectively (p < 0.0001). Patients who received chemotherapy had significantly improved OS compared to patients who did not, among both adults (p < 0.0001) and children (p = 0.004). There were no significant differences in OS based on sex, race, ethnicity and median household income. Median OS for adults diagnosed in 2000-2004, 2005-2009, 2010-2014, 2015-2019 was 4, 6, 6 and 3 months, respectively, with no significant differences in OS between these groups.

Conclusion: AEL occurs in all age groups but is most common in the elderly. Outcomes are poor with current chemotherapeutic agents, with no improvement in the last two decades. This study stresses the urgent need for investigational agents.

Keywords: acute myeloid leukemia; chemotherapy; hypomethylating agents; overall survival; pure erythroid leukemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Age distribution dichotomized based on gender for patients (n = 968) who met inclusion criteria.
Figure 2
Figure 2
Overall Survival based on age (p < 0.0001).
Figure 3
Figure 3
Overall survival based on treatment with chemotherapy for PEL (age ≥ 18 years), p < 0.0001.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Khoury J.D., Solary E., Abla O., Akkari Y., Alaggio R., Apperley J.F., Bejar R., Berti E., Busque L., Chan J.K.C., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36:1703–1719. doi: 10.1038/s41375-022-01613-1. - DOI - PMC - PubMed
    1. Arber D.A., Orazi A., Hasserjian R., Thiele J., Borowitz M.J., Le Beau M.M., Bloomfield C.D., Cazzola M., Vardiman J.W. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405. doi: 10.1182/blood-2016-03-643544. - DOI - PubMed
    1. Linnik Y., Batukbhai B., Loo E. Pure erythroid leukemia, presenting with pancytopenia. Images in Hematology. Clin. Case Rep. 2019;7:1829–1830. doi: 10.1002/ccr3.2357. - DOI - PMC - PubMed
    1. Wang W., Wang S.A., Medeiros L.J., Khoury J.D. Pure erythroid leukemia. Am. J. Hematol. 2017;92:292–296. doi: 10.1002/ajh.24626. - DOI - PubMed
    1. Sadahira Y., Kanzaki A., Wada H., Yawata Y. Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: Spectrin is a superior marker to glycophorin. J. Clin. Pathol. 1999;52:919–921. doi: 10.1136/jcp.52.12.919. - DOI - PMC - PubMed

LinkOut - more resources